Boothbay Fund Management’s ARS Pharmaceuticals SPRY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.32M	Buy	+75,458	New	+$1.32M	0.03%	453
2023 Q2	–	Sell	-15,319	Closed	-$99.7K	–	1991
2023 Q1	$99.7K	Buy	15,319 +3,684	+32%	+$24K	﹤0.01%	1689
2022 Q4	$99.2K	Buy	+11,635	New	+$99.2K	﹤0.01%	1548